Found 202 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Early Access Program of Lazertinib in Republic of Korea N/A This early access program will be conducted to provide access to Lazertinib...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment PHASE2 This study is a multicenter, prospective, randomized controlled Phase II cl...
Show More Location
Beijing Cancer Hospital, 52 Fucheng Road
Learn More & Join Trial
Study Conducted Among Patients With CML N/A Retrospective, non-interventional observational cohort study conducted amon...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC PHASE2 This single-arm phase II study aims to study the efficacy of a possible fir...
Show More Location
Xinqiao Hospital of Chongqing
Learn More & Join Trial
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease PHASE1 This trial is testing two novel combinations (temozolomide plus osimertinib...
Show More Location
University of Colorado Hospital
Learn More & Join Trial
MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma PHASE2 What is this study about? This is a medical research study testing a new dr...
Show More Location
Shanghai Sixth Peolple'S Hospital
Learn More & Join Trial
Phase 3 Clinical Study of AK112 for NSCLC Patients PHASE3 A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China N/A This is a multicenter, prospective, longitudinal observational study design...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment Free Remission (TFR) in CML Patients (CML-CP)Study N/A Improving the quality of life and achieving Treatment-Free Remission(TFR) i...
Show More Location
Multiple Locations
Learn More & Join Trial